Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-10-09 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
关于对外捐赠用于新冠肺炎疫情防控的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding a donation of anti-epidemic materials to support COVID-19 prevention efforts. It includes details about the donation amount, the company's social responsibility stance, and confirms that the donation does not affect the company's financial performance or shareholder interests. There is no financial data, no report attached or referenced as being published, and no mention of board changes, voting results, or other regulatory filings. The document is a regulatory announcement about a corporate social responsibility action, which does not fit into financial report categories. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2022-10-09 Chinese
关于沙棘糖浆研究成果在 Phytochemistry Letters 发表的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the publication of research results in an academic journal. It discusses the scientific achievement and its potential impact on the company but does not contain financial data, regulatory filings, or details about corporate governance, management changes, or shareholder votes. The document is short (808 characters) and serves as a public disclosure of research progress rather than a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) since it is a miscellaneous company announcement that does not fit other specific categories.
2022-10-09 Chinese
关于变更持续督导保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the continuous supervision sponsor representatives for a company involved in a public stock issuance and listing on a selected tier. It details personnel changes and includes a brief biography of the new representative. There is no financial data, no report content, and no mention of voting results or meeting materials. It is a regulatory announcement about management of the sponsorship role in the capital market process. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2022-09-19 Chinese
2022 年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2022 fourth extraordinary general meeting of shareholders of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes information about the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official results of shareholder votes on various proposals, such as stock repurchase, capital reduction, amendments to the company charter, credit application, and use of idle raised funds. There is no financial data or report content, but rather the formal declaration of voting outcomes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2635 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2022-09-13 Chinese
关于减少注册资本通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement by Inner Mongolia Datang Pharmaceutical Co., Ltd. regarding the reduction of registered capital due to the repurchase and cancellation of restricted shares from a stock incentive plan. It notifies creditors about the capital reduction and provides instructions for debt claims within a specified period. The document references relevant laws and company resolutions but does not contain financial statements or detailed financial data. It is a formal notice to creditors about a capital change, not a full financial report or earnings release. Given the nature of the announcement about capital reduction and creditor notification, it fits best under the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is SHA with high confidence.
2022-09-13 Chinese
公司章程
Governance Information Classification · 95% confidence The document is titled as the "Articles of Association" (章程) of Inner Mongolia Grand Pharmaceutical Co., Ltd. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, financial accounting, profit distribution, and other governance matters. It references relevant laws and regulations such as the Company Law of the PRC, Securities Law, and listing rules of the Beijing Stock Exchange. The content is a comprehensive governance document that sets out the internal rules and procedures of the company rather than a financial report, announcement, or meeting material. It is not an Annual Report, Interim Report, Earnings Release, nor a Proxy Statement or Voting Results. It is not a regulatory filing or announcement but a formal governance document. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-09-13 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.